Welcome to the Working Group on New TB Drugs Blog
Posted in Announcements, TB Prevention and Control Strategies, Uncategorized, Video, Voices from the Fight to Stop Tuberculosis
UPDATE Exposed: Aeras’ Film Series on Tuberculosis
Release of Chapter 1 of EXPOSED occured the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals – an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher – bringing viewers to the forefront of the race against tuberculosis. Click article to view the trailer and Chapter 1 “The Global Epidemic”.
Tagline Spring 2013: 3 Articles on TB Research
Treatment Action Group (TAG) recently released its Spring 2013 issue of tagline, which contains three articles about TB research that might be of interest to you– 1) on rifapentine research and access, 2) on adaptive clinical trial designs, and 3) on pediatric drug development needs.
New Database Tracks Health Technology Innovations
The Center for Health Market Innovations (CHMI) has compiled profiles on over 1,200 programs and counting. For TB innovations, the CHMI database contains 58 programs that work on TB in 33 countries.
Posted in Announcements, Events, TB Drug Development, TB News, TB Prevention and Control Strategies
Get Ready for World TB Day March 24, 2013!
World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.
Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx
The FDA granted Janssen’s TB drug Bedaquiline accelerated approval for treatment of MDR-TB. A link is provided to the FDA press release and Janssen’s full press release is included.
WHO Releases Global Tuberculosis Report 2012
The WHO released the Global Tuberculosis Report 2012 today. The main highlights and additional coverage are included.
Posted in Front Lines of TB R&D, TB R&D Spotlight Interviews, Uncategorized, Video, Voices from the Fight to Stop Tuberculosis
Immunotherapeutic Vaccines, TB and China: Interview with Dr. Douglas Lowrie
This week we highlight an interview with Dr. Douglas Lowrie, a Senior Research Fellow at Fudan University’s Shanghai Public Health Clinical Center in China. He discusses the extent of the problem of TB in China and innovative research on enhancing TB treatment using immunotherapeutic vaccines.
TB R&D Weekly Update: High Dose Vitamin D May Enhance TB Treatment
This week we highlight a study showing promising results that providing high dose vitamin D supplements along with antibiotics could improve treatment outcomes for TB patients. The abstract and additional news coverage are included, as well as, links to other TB R&D news.
2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur
We will have our 2012 Annual Meeting in Kuala, Lumpur on Wednesday, November 14 at the Impiana KLCC Hotel from 13:00 to 17:30. The meeting will be held in conjunction with the 43rd Union World Conference on Lung Health.
TB R&D Weekly Update: Results from First Novel Regimen Trial Published
Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet. The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. Link to article, press release, and related video are included. Additional links to TB R&D news are also included.
-
Toppix TB News- Detection of second-line drug resistance in mycobacterium... 24 May 2013
- Effect of Isoniazid Shortage on TB Care 24 May 2013
- Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 23 May 2013
- Impact of a Shortage of First-Line Antituberculosis Medication on... 23 May 2013
- TB, a neglected disease in Uganda 15 May 2013
